Concert Pharmaceuticals Inc. sell StockNews.com
Start price
12.03.23
/
50%
€7.88
Target price
12.03.24
-
Performance (%)
0.00%
End price
13.03.24
-
Summary
This prediction is currently being closed. StockNews_com's SELL prediction for Concert Pharmaceuticals Inc. is currently unchanged. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Concert Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% |
Comments by StockNews_com for this prediction
In the thread Concert Pharmaceuticals Inc. diskutieren
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CNCE provided by MarketBeat
In the thread Trading Concert Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten